FDA-cleared neurocognitive assessment

Objective cognitive measurement for behavioral health & psychiatry.

Quantify cognitive change tied to a condition, a medication adjustment, or a course of treatment — in about 5 minutes per assessment. Built for outpatient psychiatry, telepsychiatry, behavioral-health groups, ADHD clinics, PTSD and trauma programs, and interventional psychiatry (TMS, ketamine/esketamine).

Schedule a Demo See the workflow

5-minute assessment
Telehealth-friendly
HIPAA
21 CFR Part 11
BAA available

Why objective cognition in psychiatry

Symptom scales capture how patients feel. DANA measures how they perform.

PHQ-9s and interviews are essential — and incomplete. DANA adds an objective measure of speed and accuracy, so cognitive change can be tied to a diagnosis under care, a medication change, or a treatment course, and documented in the record.

Measure within-person change against each patient's own baseline — before and during medication adjustments.
Bring objective data to TMS and ketamine/esketamine treatment courses, from baseline through follow-up.
Complement ADHD and PTSD symptom instruments with performance data on attention, processing speed, and working memory paradigms.
Support discussions of medication effects, sleep, fatigue, mood, and function with quantified results.

Self-report vs. objective signal Illustrative

Self-reported scale DANA objective signal

Where DANA fits

Conditions, factors & treatment courses DANA helps you track.

DANA measures objective reaction time and accuracy across the conditions, factors, and treatment courses behavioral-health practices see every day. See the FDA-cleared indications for use →

Conditions & factors

Depression Anxiety PTSD ADHD Mood disorders Memory impairment Dementia Delirium Insomnia Fatigue & stress Prescription & non-prescription medication effects

Treatment courses

Medication management Talk therapy outcomes TMS treatment Ketamine / esketamine treatment

DANA measures reaction time and accuracy to aid a qualified professional's assessment — it does not diagnose these conditions. Not every item above is a named FDA-cleared indication; see the link above for the exact cleared language. DANA is not a diagnostic tool.

Built for your practice

What behavioral-health teams get.

5-minute assessment

Fits real clinic throughput and telepsychiatry sessions. Self- or clinician-administered.

Longitudinal tracking

Graphs over time against each patient's individual baseline — made for medication management.

Scored questionnaires

PHQ-9/8, GAD-7, MDQ, ASRS, PC-PTSD, PCL-C, ISI and more — standardized and auto-scored.

Web portal

Aggregated results across patients — graphs, PDF summaries, raw CSV export for documentation.

Role-aware workflow

Coordinators administer; clinicians interpret. Clean separation of roles across the practice.

Compliant & cleared

FDA-cleared; HIPAA, 21 CFR Part 11 & SOC 2 Type II compliant; BAA available; encrypted end to end.

Reimbursable

Reimbursed by commercial and federal payers when medically necessary — a revenue line for your practice, not just documentation overhead.

Program implementation & management

Our operations team works with you from day one through ongoing use to help ensure program success — we don't just hand you software and expect you to figure out workflows on your own.

The behavioral-health workflow

Baseline. Assess. Document.

A repeatable, standardized loop that fits medication management and interventional programs.

Baseline

Establish a cognitive baseline at intake or before a medication change or treatment course — about 5 minutes, in-clinic or at home.

Assess

Repeat at clinically meaningful milestones — between sessions, mid-course, at follow-up. Self-administered and telepsychiatry-friendly.

Document

Review the Brain Vital Cognitive Score against baseline, alongside auto-scored symptom scales. Export PDF summaries and CSV for the record.

Implementation model

Example: medication management pathway.

How most behavioral-health patients are actually treated — and tracked.

Establish baseline

Administer DANA before starting or adjusting a psychiatric medication — antidepressants, ADHD medications, mood stabilizers, and others.

Monitor during titration

Reassess as doses change to catch cognitive side effects — or early signs of improvement — before the next visit.

Track through ongoing care

Repeat at routine follow-ups to build a longitudinal record alongside PHQ-9, GAD-7, and other scales already in use.

Flag meaningful change

Distinguish a true medication effect from day-to-day variability using change-from-baseline data.

Support medication decisions

Give prescribers objective data to inform dose adjustments, switches, or augmentation strategies.

Document for the record

Export PDF summaries and CSV data to support the medical record and treatment-response documentation.

Whole-person view

The scales you already use — auto-scored, in the same tool.

Combine objective cognition with the standardized instruments of behavioral-health practice.

PHQ-9 Depression PHQ-8 Depression GAD-7 Anxiety MDQ Mood disorder ASRS Adult ADHD PC-PTSD PTSD screen PCL-C PTSD checklist ISI Insomnia + more

Documentation & value

Objective evidence for the record.

DANA supports objective documentation that can accompany medical-necessity discussions — baseline, intervention, and follow-up comparisons in one exportable report. When medically necessary, DANA is reimbursed by commercial and federal payers.

Request the Interpretation Report Request a Reimbursement Guide Sent to your inbox — no account required.

Next step

See DANA in a behavioral-health workflow.

Schedule a walkthrough tailored to your practice — medication management, ADHD, PTSD, or interventional psychiatry.

Schedule a Demo